Welcome to the Biomanufacturing Matchup Event, where biology meets bold ambition. EXPECTED > 200 startups | 200 investors | 1 week of virtual meetings | FreeUPDATE (APR.14) > There are already 250+ startups and 250+ investors registered! From sustainable jet fuel to protein production, from next-gen pharmaceuticals to high-performance biomaterials—there are few limits to what […]

Biotherapeutics company Prellis Biologics (IndieBio SF05 2017) has appointed Michael Nohaile, PhD as its new CEO, according to a Business Wire press release, “Prellis Biologics Appoints New CEO, Raises $35 Million in Series C Funding to Leverage Human Immune System Biology to De-Risk and Accelerate Therapeutics Drug Discovery and Development”.  The company also announced a […]

“‘Why is there no great alternative to regular animal or plastic furs?’ is the million-dollar question that led biochemist Martin Stübler to launch biomaterials company Biofluff,” wrote WWD, in its article on the plant-based fur alternative’s recent $2.5M seed round. “It was important to us not to use plant material that’s in competition with a human […]

IndieBio’s regenerative agriculture specialist Puna Bio (IndieBio SF12 2021) has secured $3.7 million in a seed round led by Builders VC and At One Ventures, TechCrunch revealed in its article “Puna Bio’s extremophile microbe menagerie survives and revives depleted soil”. Other participants in the funding round include SOSV/IndieBio, SP Ventures, Air Capital, GLOCAL, and Grid […]

The New York Times recently spotlighted Geltor, an alt-protein company in Indie Bio’s portfolio (IBSF02 2015), in the article, “Is Bio-Designed Collagen the Next Step in Animal Protein Replacement?”. The New York Times charts Geltor’s foray into the production of bio-engineered collagen, produced without any animal ingredients, and the firm’s success in working with cosmetics […]

Two Cornell-based IndieBio startups Halomine (NY 01) and Inso Biosciences (NY 03) won support from the New York State Biodefense Commercialization Fund to develop solutions that will prevent future disease outbreaks like COVID-19, the Cornell Daily Sun reported in the article “NYS Funds Cornell Startups To Combat New Disease Outbreaks”. Halomine’s primary technology, HaloFilm, extends […]

Biomaterials company BioAesthetics (IndieBio 05) has been developing a nipple-areolar complex (NAC) graft for breast cancer survivors, and New Orleans 4WWL TV News tells the story of the first successful graft in, “Breast cancer survivor receives breakthrough nipple, areola reconstruction surgery”.  Breast cancer survivors who have undergone mastectomies usually cannot keep their nipples and areolas […]

IndieBio’s Multus Biotechnology (formerly Multus Media) has raised a $9.5M Series A round to build a production facility for growth media. The UK-based startup (part of the IndieBio NY01 2020 class) received support from lead investor Mandi Ventures along with SOSV, Big Idea Ventures, SynBioVen, and Asahi Kasei Corp. The Series A raise builds on […]

In “Bio-dye maker Huue raises $14.6M, with HSBC backing”, Axios reports that Huue (IndieBio SF08 2019), a San Francisco startup developing bio-based dye, raised $14.6 million in a series A funding round led by Material Impact. Material Impact partner Corinna Chen will take a Huue board seat as part of the all-equity deal.  Participating in […]

ZymoChem (IndieBio) landed $21M from investors led by Breakout Ventures along with Toyota Ventures, lululemon, GS Ventures and SOSV. The company’s bio-based polymers have wide-ranging applications from textiles to automotive. ZymoChem converts renewable feedstocks into a variety of high-performance, bio-based, biodegradable polymers with near-zero CO2 emissions. The proprietary fermentation process improves yields by up to 50% versus […]

UK-based medical startup QV Bioelectronics (IndieBio RebelBio 08) has received £2M ($2.1M USD) in pre-series A funding to continue developing GRACE, its electric field therapy (EFT) implant. The funding round was co-led by Science Angel Syndicate and Fink Family Office, with participation from existing investors SOSV and Catapult Ventures as well as new investors Northern […]